You are here: Industry Insights > Shuwen Biotech

News List

Shuwen Biotech to Offer Breakthrough Preeclampsia Detection Device Globally through Collaboration with PerkinElmer March 02, 2020
Shuwen Biotech Co. Ltd., a China-based leader in innovative diagnostics announced that PerkinElmer, Inc. will distribute Shuwen’s breakthrough diagnostic test for preeclampsia in over 100 countries around the globe, accounting for over 120 million pregna
Tasly Pharmaceutical Group Taps Shuwen Biotech for Companion Diagnostic Services b3cnewswire
April 09, 2019
Tasly Pharmaceutical Group Taps Shuwen Biotech for Companion Diagnostic Services
Dr. Irina Buhimschi Joins Shuwen Biotech as a Scientific Advisor b3cnewswire
December 05, 2018
China-headquartered innovative diagnostic company, Shuwen Biotech, announces today that Dr. Irina Buhimschi will support its strategic plans by acting as an advisor to the company. ....
Shuwen Biotech gets PD-L1 Detection Kit validation in Clinical Trials biospectrumasia
September 18, 2018
Patients with advanced esophageal squamous cell carcinoma with higher PD-L1 expression can benefit better from leading PD-1 antibody drugs
Shuwen Biotech's Clinical Lab Successfully Passes Biyearly College of American Pathologists Audit b3cnewswire
July 24, 2018
Following a 2016 accreditation of Shuwen Biotech’s central lab, Shuwen Guanz Diagnostic Lab Co., Ltd, Shuwen is proud to announce that it has successfully passed the 2018 biannual review and was awarded a two-year extension of the CAP accreditation.
Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs b3cnewswire.
June 04, 2018
Shuwen Biotech Co. Ltd., an emerging leader in innovative diagnostic products and services announced today it has signed a partnership agreement with Bliss Biopharmaceutical Co., Ltd.
Shuwen Biotech, Bliss pharma unite for companion diagnostics of cancer biospectrumasia
May 29, 2018
Companion diagnostics and precision medicine are Shuwen’s major focus
Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development b3cnewswire
May 23, 2018
Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the development and commercialization of companion diagnostics (CDx).
Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development b3cnewswire
May 08, 2018
Abcam, a global leader in the supply of life science research tools, today signed a Memorandum of Understanding (MoU) with Shuwen Biotech, a leading player in the development and commercialization of companion diagnostics (CDx).
Shuwen Biotech Receives EN ISO 13485 Certification b3cnewswire
January 16, 2017
Shuwen Biotech Co. Ltd., a China-based diagnostic company focused on licensing, developing and commercializing diagnostic kits and services for unmet clinical needs, announced that it has received EN ISO 13485 certification.